Page last updated: 2024-10-31

mirtazapine and MS (Multiple Sclerosis)

mirtazapine has been researched along with MS (Multiple Sclerosis) in 2 studies

Mirtazapine: A piperazinoazepine tetracyclic compound that enhances the release of NOREPINEPHRINE and SEROTONIN through blockage of presynaptic ALPHA-2 ADRENERGIC RECEPTORS. It also blocks both 5-HT2 and 5-HT3 serotonin receptors and is a potent HISTAMINE H1 RECEPTOR antagonist. It is used for the treatment of depression, and may also be useful for the treatment of anxiety disorders.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Quiñones-Aguilar, S1
Sauri-Suárez, S1
Alcaraz-Estrada, SL1
García, S1
McGuire, JL1
Fridman, V1
Wüthrich, C1
Koralnik, IJ1
Jacobs, D1

Other Studies

2 other studies available for mirtazapine and MS (Multiple Sclerosis)

ArticleYear
Progressive Multifocal Leukoencephalopathy associated to treatment with natalizumab in Mexican patient Multiple Sclerosis. Case report, analysis and update.
    Neuro endocrinology letters, 2019, Volume: 40, Issue:5

    Topics: Female; Humans; Immunoglobulins; Leukoencephalopathy, Progressive Multifocal; Methylprednisolone; Me

2019
Progressive multifocal leukoencephalopathy associated with isolated CD8+ T-lymphocyte deficiency mimicking tumefactive MS.
    Journal of neurovirology, 2011, Volume: 17, Issue:5

    Topics: Aged; Brain; CD8-Positive T-Lymphocytes; Female; Humans; JC Virus; Leukoencephalopathy, Progressive

2011